The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Somatic tumor profiling of DNA mismatch repair (MMR) deficient endometrial cancers (EC).
 
Karen Anne Cadoo
Research Funding - AstraZeneca (Inst)
 
Deborah DeLair
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Magan Trottier
No Relationships to Disclose
 
Carolyn Stewart
No Relationships to Disclose
 
Christina Tran
No Relationships to Disclose
 
Yelena Kemel
Employment - BioReference Laboratories
 
Michael Francis Walsh
No Relationships to Disclose
 
Felicia Scharf
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics; Chugai Pharma; CytomX Therapeutics
Research Funding - AstraZeneca; Puma Biotechnology
 
Vijai Joseph
No Relationships to Disclose
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Biomarin (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Nadeem Abu-Rustum
No Relationships to Disclose
 
Kenneth Offit
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Carol Aghajanian
Consulting or Advisory Role - Bayer; Cerulean Pharma; Cerulean Pharma; Oxigene; VentiRx
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Optos (I); Regeneron (I)